Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities

Cell Reports(2020)10.1016/j.celrep.2020.03.073Source: DataRank Database

Hotspots of Aberrant Enhancer Activity in Fibrolamellar Carcinoma Reveal Candidate Oncogenic Pathways and Therapeutic Vulnerabilities is a research paper published in Cell Reports (2020). On theSindex it has a DataRank of 0. It has been cited 43 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access43 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.79)OA: goldTopics (36)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Ramja Sritharan ORCID,F. Donelson Smith ORCID,Adam B. Francisco ORCID,K. Rosanna ORCID,Rodica P. Bunaciu ORCID

Live enrichment

PubMed:32294439 OpenAlex:https://openalex.org/W3015297783

U.S. Department of Defense

Grant: 61-8326

National Institute of Diabetes and Digestive and Kidney Diseases

Grant: R01DK105542

FWCI

1.79

Citation Percentile

0.9%

Influential Citations

Citation Trend

2019

2020

2021

2022

2023

2024

2025

2026

goldLicense: http://creativecommons.org/licenses/by-nc-nd/4.0/

journalhttp://www.cell.com/article/S2211124720303995/pdf

GOLDhttps://www.cell.com/article/S2211124720303995/pdf

publisherhttp://www.cell.com/article/S2211124720303995/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124720303995?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124720303995?httpAccept=text/plain

Fields of Study

Genomics and Chromatin DynamicsRNA Research and SplicingUbiquitin and proteasome pathwaysMedicineBiology

MeSH Terms

AdolescentChromatinEnhancer Elements, GeneticCarcinoma, HepatocellularHumansLiverLiver NeoplasmsMembrane ProteinsOncogenesSignal TransductionGene Expression Regulation, NeoplasticSequence Analysis, DNACA-125 AntigenComputational BiologyMAP Kinase Signaling SystemMonocarboxylic Acid TransportersCell ProliferationCarcinogenesis

Keywords

EnhancerChromatinBiologyCancer researchGeneCandidate geneMAPK/ERK pathwayViability assayComputational biologyCellTranscription factorGeneticsSignal transduction

Sustainable Development Goals

SDG 0: Good health and well-being